LACTOLOGY FOUNDATION

Sodium sulfate (ATC A06AD13) is an oral osmotic laxative mainly used in bowel cleansing preparations before colonoscopy, with a local gastrointestinal mechanism of action and a lactation safety profile that is generally favourable due to minimal systemic relevance, although data in breastfeeding are limited and recommendations remain conservative.medpedia.framar+5

Pharmacological class and mechanism

Sodium sulfate is an inorganic mineral salt classified among osmotically acting laxatives (ATC A06AD13), most often formulated together with potassium sulfate and magnesium sulfate in colon cleansing solutions and tablets.medlineplus+4

As an osmotic agent in the intestinal lumen, sodium sulfate promotes retention of water in the bowel, increasing stool water content, softening stool and enhancing colonic motility and evacuation.mayoclinic+4

The resulting watery diarrhoea leads to effective mechanical cleansing of the colon, improving visualisation of the colonic mucosa during colonoscopy and other diagnostic procedures such as barium enema.drugbank+4

Therapeutic indications and dosing

Within class A06AD13, sodium sulfate‑containing preparations are indicated for bowel cleansing prior to colonoscopy or radiological examination of the large intestine, in adults and, for some products, adolescents from 12 years of age.wikidoc+4

Bulgarian product information highlights use “for irrigation of the colon prior to diagnostic procedures,” consistent with international indications.cancer+3

Typical dosing regimens employ split‑dose schedules, with the solution or tablets administered the evening before and on the morning of the procedure, in total volumes of approximately 2.8–3 litres of liquid for complete colonic cleansing.clevelandclinic+4

Locally, a sachet of sodium sulfate powder is dissolved in 1 litre of water, and the usual dose is 1 litre per 15–20 kg body weight, starting from the day before the diagnostic procedure.medpedia.framar

Dietary restrictions (clear liquids only, avoidance of red or purple liquids and solid foods) are recommended around dosing to optimise cleansing and prevent misinterpretation of luminal contents.webmd+3

Pharmacokinetics and systemic exposure

Sodium sulfate acts primarily within the gut lumen, and in colon‑prep doses its clinical effect is due to osmotic water retention and stimulation of intestinal motility rather than systemic absorption.dailymed.nlm.nih+4

Although sulphate ions can be absorbed from the gut, the transient nature of the preparation regimen and the predominant local action limit sustained systemic exposure in otherwise healthy individuals.dailymed.nlm.nih+3

In combination products, the overall osmotic burden arises from sodium, potassium and magnesium sulfates collectively, with fluid shifts and electrolyte changes more clinically relevant than classic systemic pharmacodynamics.cancer+3

Accordingly, pharmacokinetic considerations in risk assessment focus on fluid–electrolyte balance and renal and cardiac reserve rather than on xenobiotic toxicity per se.clevelandclinic+3

Adverse effects, contraindications and toxicity

Common adverse effects during sodium sulfate bowel prep include nausea, vomiting, bloating, abdominal pain, and pronounced diarrhoea, all directly related to the intended laxative effect and osmotic fluid shifts.mayoclinic+4

Serious reactions, although less frequent, include dehydration, hypotension, syncope, electrolyte disturbances (such as hyponatraemia or hypokalaemia), and arrhythmias, particularly in vulnerable patients or when fluid intake is inadequate.webmd+4

Hypersensitivity reactions have been reported, ranging from rash and urticaria to rare anaphylactic shock, necessitating immediate discontinuation and emergency management.dailymed.nlm.nih+3

Contraindications listed in Bulgarian and international sources include severe cardiac failure, significant dehydration, gastrointestinal neoplasia, ileus and acute surgical abdomen; sodium sulfate‑based preps are also not suitable for children below certain age thresholds (for example under 12–15 years, depending on the product).medlineplus+4

From a toxicological standpoint, acute overdose manifests as intense diarrhoea, vomiting, severe fluid loss and electrolyte imbalance, and is managed by discontinuation, rehydration and correction of electrolytes, with careful monitoring of cardiovascular status.medpedia.framar+3

In chronic high intake outside medical use, theoretical concerns include sustained electrolyte load and renal stress, but such scenarios are not part of standard therapeutic practice for A06AD13 medicines.drugbank+2

Use in pregnancy and lactation

Data on the use of sodium sulfate bowel preparations in pregnant women are limited, and colonoscopy itself is usually reserved for situations where the expected benefits outweigh potential risks to the mother and fetus.wikidoc+3

Given the short‑term, single‑course nature of the regimen and the lack of specific teratogenic signals, risk assessment in pregnancy focuses mainly on procedural aspects and fluid–electrolyte effects rather than on direct embryotoxicity.dailymed.nlm.nih+3

For breastfeeding, e‑Lactancia classifies sodium sulfate as “Very Low Risk – Compatible,” noting that no published data on excretion into breast milk are available but that its structure and local mechanism are consistent with low expected risk.e-lactation

As an osmotic laxative used in one or two doses for colon cleansing, sodium sulfate is unlikely to reach breast milk in clinically significant amounts, and any infant exposure would be minimal and transient.e-lactation+3

Given the absence of direct measurements in human milk, prudent practice during lactation includes using sodium sulfate preparations only when colonoscopy is clearly indicated, maintaining adequate maternal hydration, and monitoring the breastfed infant for unusual gastrointestinal symptoms.breastfeedingnetwork+3

Alternative bowel prep regimens may be considered on an individual basis if there are concerns about maternal comorbidities or infant vulnerability, ideally in consultation with a clinician experienced in breastfeeding pharmacotherapy.cdc+3

Practical lactation‑toxicology considerations

In breastfeeding women who require colonoscopy with sodium sulfate‑based bowel prep, the main toxicological issues are procedure‑related fluid and electrolyte shifts in the mother, rather than any direct chemical toxicity to the infant via breast milk.clevelandclinic+4

The very low risk classification and absence of documented adverse effects in breastfed infants support continuation of breastfeeding, although some clinicians may recommend timing feeds or expressing milk around the procedure to accommodate maternal discomfort and fasting requirements.clevelandclinic+3

Where possible, documentation of dose, timing, breastfeeding pattern and any observed infant effects contributes to better characterisation of sodium sulfate’s lactation safety profile in real‑world settings.e-lactation+2